R H Levy

CONGRES FISITA 1988, DEARBORN, MICHIGAN - WASHINGTON D.C., USA, 25-30 SEPT. 1988

D Laforgia, R H Levy, R B Smith, 1988 .

Carbamazepine Plus Stiripentol: Is Poly therapy by Design Possible?

R H Levy, J. Lockard, J S Lockard, 1988, Epilepsia.

Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450.

R H Levy, W. Trager, J. Keirns, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Influence of stiripentol on cytochrome P450‐mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants

R H Levy, W. Trager, K. Thummel, 1997, Clinical pharmacology and therapeutics.

Are Circulating Metabolites Important in Drug–Drug Interactions?: Quantitative Analysis of Risk Prediction and Inhibitory Potency

R H Levy, N. Isoherranen, H. Hachad, 2011, Clinical pharmacology and therapeutics.

Rationale for Monitoring Free Drug Levels

R H Levy, T. Moreland, R. Levy, 1984, Clinical pharmacokinetics.